In a crowded playing field of biomedical data providers, a company in Scranton is standing out by consistently expanding the types and amount of information it provides to life sciences companies worldwide. Life Science Analytics, which employs 20 in their office in a restored silk mill, grew by more than 30 percent in the first half of 2009 and is positioned to continue its ascent.
“We have a lot of competitors, but the advantage we have is we’re a one-stop shop where we cover everything,” says Tish Giglio, product analyst for LSA. “We combine financial data with pipeline data and venture deals. We have our hands in everything, while competitors may have one focus, like trial details.”
LSA is one of the most profitable holdings of parent company The Datamonitor Group, the U.K. outfit that purchased it in 2005, and provides information on 130,000 biomedical companies worldwide to more than 800 subscribers (life sciences companies across the globe). LSA eliminates a lot of legwork for business development types with its MedTRACK database, which systemizes pipeline, financial, competitive product, mechanism of action, partnering and patent information. The data can be sorted by parameters like disease or clinical trial stage and searched by SEC filings, websites, news and product descriptions.
LSA also features a report center that creates 5,000 reports every month based on MedTRACK’s data, like therapeutic areas, as well as databases that track deals and alliances and venture finance. This week, the company launched its Global Financials data set. With so much additional data–the company was tracking only 1,300 companies for 106 subscribers in 2003–LSA is working on a new version of MedTRACK that will transform the architecture of the database.
Source: Tish Giglio, Life Science Analytics
Writer: Joe Petrucci
